SynBiotic SE (SBX.DE)
4.56 €
+0.14 (+3.17%)
Rating:
Recommendation:
-
| Symbol | SBX.DE |
|---|---|
| Price | 4.56 € |
| Beta | 5.166 |
| Volume Avg. | 0.02M |
| Market Cap | 24.864M |
| Shares () | - |
| 52 Week Range | 3.39-16.0 |
| 1y Target Est | - |
| DCF Unlevered | SBX.DE DCF -> | |
|---|---|---|
| DCF Levered | SBX.DE LDCF -> | |
| ROE | -84.60% | Strong Sell |
| ROA | -59.97% | Strong Sell |
| Operating Margin | - | |
| Debt / Equity | 19.70% | Neutral |
| P/E | -0.89 | |
| P/B | - |
About
Download (Excel)Mr. Lars Muller
Healthcare
Drug Manufacturers—Specialty & Generic
Frankfurt Stock Exchange
SynBiotic SE engages in the development of medicines and over-the-counter wellness products based on cannabinoids. It focuses on synthetic production of cannabinoids, drug development, nutritional supplements, and cosmetic products. The company was formerly known as Ledgertech SE and changed its name to Ledgertech SE. SynBiotic SE based in Munich, Germany.